Alexandre E Voskuyl
Overview
Explore the profile of Alexandre E Voskuyl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
167
Citations
4108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Broens B, Nossent E, Meijboom L, Zwezerijnen G, Spierings J, de Vries-Bouwstra J, et al.
Arthritis Res Ther
. 2024 Dec;
26(1):219.
PMID: 39702262
Background: This study aimed to assess the quantitative uptake of F-FDG PET-CT in the lungs of patients with early severe diffuse cutaneous systemic sclerosis (SSc) with and without interstitial lung...
2.
Loeff F, Parodis I, Walhelm T, Jonsen A, Nikolopoulos D, Sjowall C, et al.
J Immunol Methods
. 2024 Jul;
532:113717.
PMID: 38960066
Monitoring belimumab concentrations in patients can be a valuable tool for assessing treatment response and for personalizing drug doses. Various assay formats may be used to measure concentrations of therapeutic...
3.
El Hadiyen F, Tsang-A-Sjoe M, Lissenberg-Witte B, Voskuyl A, Bultink I
Lupus Sci Med
. 2024 Jul;
11(2).
PMID: 38955402
Objective: To determine whether intercurrent infections are a risk factor for subsequent disease flares in systemic lupus erythematosus (SLE). Methods: Demographic and clinical characteristics of 203 patients with SLE participating...
4.
Agca R, Popa C, Heymans M, Crusius B, Voskuyl A, Nurmohamed M
Arthritis Care Res (Hoboken)
. 2024 Jun;
76(10):1419-1426.
PMID: 38923367
Objective: Current risk algorithms do not accurately predict cardiovascular disease (CVD) risk in rheumatoid arthritis (RA). An area of interest is that of single-nucleotide polymorphisms (SNPs), of which several have...
5.
Stalman E, Wieske L, Keijser J, van Dam K, Kummer L, Wilbrink M, et al.
J Allergy Clin Immunol
. 2024 May;
154(3):754-766.e7.
PMID: 38763170
Background: Despite impaired humoral response in patients treated with immunosuppressants (ISPs), recent studies found similar severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection compared to controls. One...
6.
Blomjous B, de Boer M, van Weissenbruch M, Laan K, Rispens T, Voskuyl A, et al.
Lupus Sci Med
. 2024 Mar;
11(1).
PMID: 38499356
No abstract available.
7.
Broens B, Zwezerijnen B, van der Laken C, Voskuyl A
Lancet Rheumatol
. 2024 Jan;
3(7):e475.
PMID: 38279399
No abstract available.
8.
Boekel L, Atiqi S, Leeuw M, Hooijberg F, Besten Y, Wartena R, et al.
Lancet Rheumatol
. 2023 Jul;
5(7):e375-e385.
PMID: 37398978
Background: Studies on long-term consequences of COVID-19, commonly referred to as post-COVID condition, in patients with inflammatory rheumatic diseases are scarce and inconclusive. Furthermore, classifying patients with inflammatory rheumatic diseases...
9.
van Dam K, Volkers A, Wieske L, Stalman E, Kummer L, van Kempen Z, et al.
BMC Infect Dis
. 2023 May;
23(1):332.
PMID: 37198536
Background: Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs) may have impaired long-term humoral immune responses and increased disease activity after SARS-CoV-2 infection. We aimed to investigate long-term humoral...
10.
Vegting Y, Penne E, Hilhorst M, Hoekstra T, Bemelman F, Vogt L, et al.
Joint Bone Spine
. 2023 Feb;
90(4):105540.
PMID: 36758893
Objectives: ANCA-associated vasculitis (AAV) has been associated with increased risk of cardiovascular (CV) events. The aim was to assess traditional and disease-related CV risk determinants in a two-centre prospective cohort...